Researchers Debate Ezetimibe (Vytorin) ENHANCE Trial -Part 3

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
493 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Apr 18, 2008

http://www.medpagetoday.com
Evan A. Stein, M.D., Ph.D., Metabolic and Atherosclerosis Research Center in Cincinnati

Allen J. Taylor, M.D., of the Uniformed Services University of the Health Sciences Walter Reed Army Medical Center in Washington

Controversy over the ENHANCE trial continued despite lengthy presentations at the American College of Cardiology meeting earlier this month. In this exclusive video report MedPage Today talks in-depth with two researchers about ezetimibe, LDL, and clinical implications of the trial.

Category:

Education

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • This series is the most informative and balanced report that I have seen on this subject. Everyone who has an interest in this subject, should take the time to view all three of these rports. I think that the last comment that more people could die in the next two years than all the people who died in Iraq if Vytorin is taken off the shelves, is striking and graphically illustrates the point.

    Gene Costa

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more